Hey guys!
Is anyone here currently enrolled in (or know someone who is) this triple therapy trial at the Ohio State Univ? I'm really interested in this, as it looks at both previously treated and untreated. Perhaps early intervention with several drugs will eradicate the clone and prevent selective pressures that give rise to resistance!
Lurking. 😃
There are a couple of people who have chronicled their experiences on cllforum.com, Clinical Trials, Starting Obinutuzumab-Ibrutinub-Venetoclax (abt199) topic. I have an appt today and am hoping to be enrolled as a previously untreated patient and if I am, I will be happy to document everything that happens as reading the forum above was extremely helpful for me.
Zanubrutinib, Obinutuzumab and Venetoclax. Front line Clinical Trial.
Update- My Imbruvica plus Venetoclax Captivate trial. 
Vaccine with Venclexta 
Going to OSU for Second Opinion
Obinutuzumab (gazyva)
